NCT03276806

Brief Summary

Current smokers who undergo annual low dose CT (LDCT) lung cancer screening and successfully quit smoking derive the greatest reduction in lung cancer mortality. Unfortunately, those at highest risk of lung cancer death- those with low socioeconomic status, blacks, and current smokers- are the same individuals that typically have reduced access to preventive healthcare such as smoking cessation services and screening tests. Furthermore, patients from underserved communities often have lower health literacy, less awareness of lung cancer screening, and a poor understanding of the trade-offs of LDCT screening. In 2015 the Center for Medicare and Medicaid Services began requiring (1) a shared decision-making (SDM) discussion including use of a patient decision aid and (2) smoking cessation counseling in order to receive reimbursement for LDCT screening. There is little guidance, however, to help healthcare systems implement this requirement. Furthermore, primary care physicians (PCPs) report time constraints, competing demands, and knowledge deficiencies as barriers to optimizing utilization of LDCT screening.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable lung-cancer

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 5, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 8, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

November 7, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
Last Updated

July 5, 2019

Status Verified

July 1, 2019

Enrollment Period

1.4 years

First QC Date

September 5, 2017

Last Update Submit

July 2, 2019

Conditions

Keywords

CT low dosenurse led interventionsafety net hospitallung cancer screening with CTLD

Outcome Measures

Primary Outcomes (1)

  • Completion of LDCT screening

    The electronic records review and from the Lung Cancer Screening clinical database created by the Department of Pulmonary Disease and Critical Care at BMC will be reviewed to determine which participants have completed LDCT screening designated as yes or no and if yes the date of the LDCT screening will be recorded..

    3 months

Secondary Outcomes (3)

  • Knowledge of LDCT screening (experimental group)

    Baseline, immediately post SDM, 1 month

  • Knowledge of LDCT screening (active comparator group)

    Baseline, 1 month

  • smoking cessation

    4 weeks

Study Arms (2)

SDM + decision aid + tobacco counseling

EXPERIMENTAL

Participants will receive tobacco dependence/smoking cessation counseling by a nurse, SDM and a decision aid.

Behavioral: tobacco dependence/smoking cessation counselingBehavioral: SDMOther: Decision Aid

LDCT brochure + tobacco counseling

ACTIVE COMPARATOR

Participants will receive tobacco dependence/smoking cessation counseling by a nurse and a LDCT informational brochure.

Behavioral: tobacco dependence/smoking cessation counselingOther: LDCT brochure

Interventions

Standard of care tobacco dependence/smoking cessation counseling offered to all smokers at Boston Medical Center.

LDCT brochure + tobacco counselingSDM + decision aid + tobacco counseling
SDMBEHAVIORAL

SDM is three-fold to: 1) conduct a tailored discussion on tradeoffs of LDCT screening, consistent with CMS requirements for SDM using a decision aid; 2) directly connect interested patients to LDCT screening; 3) to empower and motivate patients to quit smoking within the LDCT screening context.

Also known as: Shared decision making
SDM + decision aid + tobacco counseling

The decision aid is a 4-page paper format with the following features: 1) LDCT screening harms and benefits information, written in plain language and using pictographs, easily understood by those with low health literacy; 2) prompts to clarify patient values and preferences and to stimulate discussion about trade-offs; 3) clear quit smoking messaging and resources (1-800-QUIT-NOW).

SDM + decision aid + tobacco counseling

A informational brochure developed by the BMC screening program about low dose CT screening for lung cancer.

LDCT brochure + tobacco counseling

Eligibility Criteria

Age55 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • hospitalized smokers at BMC meeting LDCT screening eligible criteria
  • males and females 55-80 years of age
  • ≥30-pack years smoking
  • current smoker
  • able to speak, read, and understand English
  • able and willing to participate and provide informed consent

You may not qualify if:

  • severe co-morbidities expected to limit life expectancy or ability to tolerate surgical resection of a lung cancer, including patients requiring home oxygen therapy (an indicator of severe lung or heart disease), and patients with active cancer
  • patients who have already had LDCT screening in the past year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Medical Center

Boston, Massachusetts, 02118, United States

Location

Related Publications (1)

  • Kathuria H, Gunawan A, Spring M, Aijaz S, Cobb V, Fitzgerald C, Wakeman C, Howard J, Clancy M, Foreman AG, Truong V, Wong C, Steiling K, Lasser KE, Bulekova K, Wiener RS. Hospitalization as an opportunity to engage underserved individuals in shared decision-making for lung cancer screening: results from two randomized pilot trials. Cancer Causes Control. 2022 Nov;33(11):1373-1380. doi: 10.1007/s10552-022-01620-8. Epub 2022 Aug 23.

MeSH Terms

Conditions

Lung Neoplasms

Interventions

SDMDecision Support Techniques

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Hasmeena Kathuria, MD

    Assistant Professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 5, 2017

First Posted

September 8, 2017

Study Start

November 7, 2017

Primary Completion

April 1, 2019

Study Completion

July 1, 2019

Last Updated

July 5, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations